BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang MJ, Wei RB, Wang Y, Su TY, Di P, Li QP, Yang X, Li P, Chen XM. Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ Open 2017;7:e014294. [PMID: 28576889 DOI: 10.1136/bmjopen-2016-014294] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Sepehri A, Sidhu A, Masri BA. Total Hip Replacements in Patients with Rare Pathologic Conditions Affecting Bone. J Bone Joint Surg Am 2021;103:1355-62. [PMID: 33780390 DOI: 10.2106/JBJS.20.01398] [Reference Citation Analysis]
2 Baralić M, Robajac D, Penezić A, Miljuš G, Šunderić M, Gligorijević N, Nedić O. Fibrinogen Modification and Fibrin Formation in Patients with an End-Stage Renal Disease Subjected to Peritoneal Dialysis. Biochemistry (Mosc) 2020;85:947-54. [PMID: 33045955 DOI: 10.1134/S0006297920080106] [Reference Citation Analysis]
3 Wu S, Yuan H, Zhou Y, Long Z, Peng Y, Peng F. [Thromboelastography-based assessment of coagulation function in patients with chronic kidney disease and the risk factors of hypercoagulability]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:556-61. [PMID: 32895144 DOI: 10.12122/j.issn.1673-4254.2020.04.17] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kao CC, Wu MS, Chuang MT, Lin YC, Huang CY, Chang WC, Chen CW, Chang TH. Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease. PLoS One 2021;16:e0255645. [PMID: 34347826 DOI: 10.1371/journal.pone.0255645] [Reference Citation Analysis]
5 Marini S, Georgakis MK, Anderson CD. Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together. Front Neurol 2021;12:785273. [PMID: 34899586 DOI: 10.3389/fneur.2021.785273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Barnett LMA, Kramer NE, Buerger AN, Love DH, Bisesi JH Jr, Cummings BS. Transcriptomic Analysis of the Differential Nephrotoxicity of Diverse Brominated Flame Retardants in Rat and Human Renal Cells. Int J Mol Sci 2021;22:10044. [PMID: 34576211 DOI: 10.3390/ijms221810044] [Reference Citation Analysis]
7 Makhloufi C, Crescence L, Darbousset R, McKay N, Massy ZA, Dubois C, Panicot-Dubois L, Burtey S, Poitevin S. Assessment of Thrombotic and Bleeding Tendency in Two Mouse Models of Chronic Kidney Disease: Adenine-Diet and 5/6th Nephrectomy. TH Open 2020;4:e66-76. [PMID: 32309772 DOI: 10.1055/s-0040-1705138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Emleek EMQ, Khalil AA. Disseminated Intravascular Coagulopathy in Critically Ill Patients in Amman, Jordan. Biol Res Nurs 2021;:10998004211017241. [PMID: 34030507 DOI: 10.1177/10998004211017241] [Reference Citation Analysis]
9 Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation. Oxid Med Cell Longev 2021;2021:6651367. [PMID: 33628373 DOI: 10.1155/2021/6651367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Yamakage S, Oe Y, Sato E, Okamoto K, Sekimoto A, Kumakura S, Sato H, Yoshida M, Nagasawa T, Miyazaki M, Ito S, Mackman N, Takahashi N. Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet. Sci Rep 2021;11:12159. [PMID: 34108522 DOI: 10.1038/s41598-021-91586-5] [Reference Citation Analysis]
11 van der Vorm LN, Visser R, Huskens D, Veninga A, Adams DL, Remijn JA, Hemker HC, Rensma PL, van Horssen R, de Laat B. Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease. Clin Kidney J 2020;13:72-4. [PMID: 32082555 DOI: 10.1093/ckj/sfz076] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
12 Addi T, Poitevin S, McKay N, El Mecherfi KE, Kheroua O, Jourde-Chiche N, de Macedo A, Gondouin B, Cerini C, Brunet P, Dignat-George F, Burtey S, Dou L. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells. Arch Toxicol 2019;93:121-36. [PMID: 30324315 DOI: 10.1007/s00204-018-2328-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
13 Garcia-Nicoletti M, Sinha MD, Savis A, Adalat S, Karunanithy N, Calder F. Silent and dangerous: catheter-associated right atrial thrombus (CRAT) in children on chronic haemodialysis. Pediatr Nephrol 2021;36:1245-54. [PMID: 33125532 DOI: 10.1007/s00467-020-04743-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Jain N, Corken A, Kumar A, Davis C, Ware J, Arthur J. Role of Platelets in Chronic Kidney Disease. J Am Soc Nephrol 2021:ASN. [PMID: 34140394 DOI: 10.1681/ASN.2020121806] [Reference Citation Analysis]
15 Gal-Oz A, Papushado A, Kirgner I, Meirsdorf S, Schwartz D, Schwartz IF, Zubkov A, Grupper A. Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy. Ren Fail 2020;42:10-8. [PMID: 31842662 DOI: 10.1080/0886022X.2019.1700805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Tang SCW, Yiu WH. Innate immunity in diabetic kidney disease. Nat Rev Nephrol 2020;16:206-22. [PMID: 31942046 DOI: 10.1038/s41581-019-0234-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 20.5] [Reference Citation Analysis]
17 He W, Zhang H, Zhu W, Xue Z. Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation: A meta-analysis. Medicine (Baltimore) 2019;98:e17628. [PMID: 31626146 DOI: 10.1097/MD.0000000000017628] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Auer J, Lamm G. The role of aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease. Eur J Prev Cardiol 2021:zwab149. [PMID: 34599597 DOI: 10.1093/eurjpc/zwab149] [Reference Citation Analysis]
19 Lok SWY, Yiu WH, Li H, Xue R, Zou Y, Li B, Chan KW, Chan LYY, Leung JCK, Lai KN, Tang SCW. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis. Clin Sci (Lond) 2020;134:2873-91. [PMID: 33078834 DOI: 10.1042/CS20200923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Humphries TLR, Shen K, Iyer A, Johnson DW, Gobe GC, Nikolic-Paterson D, Fairlie DP, Vesey DA. PAR2-Induced Tissue Factor Synthesis by Primary Cultures of Human Kidney Tubular Epithelial Cells Is Modified by Glucose Availability. Int J Mol Sci 2021;22:7532. [PMID: 34299151 DOI: 10.3390/ijms22147532] [Reference Citation Analysis]
21 Meade RD, Akerman AP, Notley SR, McGinn R, Poirier P, Gosselin P, Kenny GP. Physiological factors characterizing heat-vulnerable older adults: A narrative review. Environ Int 2020;144:105909. [PMID: 32919284 DOI: 10.1016/j.envint.2020.105909] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
22 Tsai MH, Liou HH, Huang YC, Lee TS, Chen M, Fang YW. Hazardous Effect of Low-Dose Aspirin in Patients with Predialysis Advanced Chronic Kidney Disease Assessed by Machine Learning Method Feature Selection. Healthcare (Basel) 2021;9:1484. [PMID: 34828530 DOI: 10.3390/healthcare9111484] [Reference Citation Analysis]
23 Shropshire S, Johnson T, Olver C. Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein-losing nephropathy. J Vet Intern Med 2020;34:710-8. [PMID: 31981378 DOI: 10.1111/jvim.15694] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Al-amodi HS, Abdelbasit NA, Fatani SH, Babakr AT, Mukhtar MM. The effect of obesity and components of metabolic syndrome on leptin levels in Saudi women. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018;12:357-64. [DOI: 10.1016/j.dsx.2017.12.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Pallikadavath S, Ashton L, Brunskill NJ, Burton JO, Gray LJ, Major RW. Aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. Eur J Prev Cardiol 2021:zwab132. [PMID: 34448849 DOI: 10.1093/eurjpc/zwab132] [Reference Citation Analysis]
26 Ma HY, Chen S, Du Y. Estrogen and estrogen receptors in kidney diseases. Ren Fail 2021;43:619-42. [PMID: 33784950 DOI: 10.1080/0886022X.2021.1901739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Fryc J, Naumnik B. Thrombolome and Its Emerging Role in Chronic Kidney Diseases. Toxins (Basel) 2021;13:223. [PMID: 33803899 DOI: 10.3390/toxins13030223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Horinouchi Y, Ikeda Y, Fukushima K, Imanishi M, Hamano H, Izawa-Ishizawa Y, Zamami Y, Takechi K, Miyamoto L, Fujino H, Ishizawa K, Tsuchiya K, Tamaki T. Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis. Sci Rep 2018;8:10858. [PMID: 30022146 DOI: 10.1038/s41598-018-29008-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
29 Cunha RSD, Santos AF, Barreto FC, Stinghen AEM. How do Uremic Toxins Affect the Endothelium? Toxins (Basel) 2020;12:E412. [PMID: 32575762 DOI: 10.3390/toxins12060412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Rattazzi M, Villalta S, De Lucchi L, Sponchiado A, Galliazzo S, Faggin E, Pagliara V, Zilli C, Callegari E, Caberlotto L, Puato M, Pauletto P. Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence. Thromb Res 2017;160:32-7. [PMID: 29091810 DOI: 10.1016/j.thromres.2017.10.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
31 Shafiee MA, Hosseini SF, Mortazavi M, Emami A, Mojtahed Zadeh M, Moradi S, Shaker P. Anticoagulation therapy in COVID-19 patients with chronic kidney disease. J Res Med Sci 2021;26:63. [PMID: 34729071 DOI: 10.4103/jrms.JRMS_875_20] [Reference Citation Analysis]
32 Huang M, Wei R, Wang Y, Su T, Li P, Chen X. The uremic toxin hippurate promotes endothelial dysfunction via the activation of Drp1-mediated mitochondrial fission. Redox Biol 2018;16:303-13. [PMID: 29573704 DOI: 10.1016/j.redox.2018.03.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
33 Kaminski TW, Pawlak K, Karbowska M, Mysliwiec M, Grzegorzewski W, Kuna J, Pawlak D. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease. Int Urol Nephrol 2018;50:127-35. [PMID: 29058166 DOI: 10.1007/s11255-017-1729-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
34 Chopra H, Dey PS, Das D, Bhattacharya T, Shah M, Mubin S, Maishu SP, Akter R, Rahman MH, Karthika C, Murad W, Qusty N, Qusti S, Alshammari EM, Batiha GE, Altalbawy FMA, Albooq MIM, Alamri BM. Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets. Molecules 2021;26:4998. [PMID: 34443593 DOI: 10.3390/molecules26164998] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Yasuda K, Fukuda S, Nakamura M, Ohtani R, Kuwata Y, Takata M, Sainouchi M, Gotou M, Masuda Y, Kawarazaki S, Kawabata Y, Murase N, Aoki T, Yonemoto N, Akao M, Tsukahara T. Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry. Cerebrovasc Dis Extra 2018;8:50-9. [PMID: 29788021 DOI: 10.1159/000488206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Pavlou EG, Georgatzakou HT, Fortis SP, Tsante KA, Tsantes AG, Nomikou EG, Kapota AI, Petras DI, Venetikou MS, Papageorgiou EG, Antonelou MH, Kriebardis AG. Coagulation Abnormalities in Renal Pathology of Chronic Kidney Disease: The Interplay between Blood Cells and Soluble Factors. Biomolecules 2021;11:1309. [PMID: 34572522 DOI: 10.3390/biom11091309] [Reference Citation Analysis]
37 Alfadda AA, AlKhowaiter M, Alotaibi N, Alayed K, Alzahrani M, Binkhamis K, Siddiqui K, Youssef A, Altalhi H, Almaghlouth I, Alarifi M, Albanyan S, Alosaimi MF, Hasanato R, Isnani A, Dekhil H, Rafiullah M. Clinical and biochemical characteristics and outcomes of suspected COVID-19 hospitalized patients: RT-PCR swab positive and negative comparison. J Infect Public Health 2021;14:1623-9. [PMID: 34624717 DOI: 10.1016/j.jiph.2021.09.014] [Reference Citation Analysis]
38 Xia M, Liu D, Peng L, Li Y, Liu H, Wu L, Chen G, Liu Y, Liu H. Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study. BMC Nephrol 2020;21:447. [PMID: 33109129 DOI: 10.1186/s12882-020-02111-1] [Reference Citation Analysis]
39 Hansen ES, Rinde FB, Edvardsen MS, Hindberg K, Latysheva N, Aukrust P, Ueland T, Michelsen AE, Hansen JB, Brækkan SK, Morelli VM. Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism. Thromb Res 2021;208:121-6. [PMID: 34763296 DOI: 10.1016/j.thromres.2021.10.020] [Reference Citation Analysis]
40 Ghosh K, Ghosh K. D-dimer: an analyte with increasing application in Covid-19 infection. Expert Rev Hematol 2022. [PMID: 35262442 DOI: 10.1080/17474086.2022.2052040] [Reference Citation Analysis]
41 Baaten CCFMJ, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H. Platelet Function in CKD: A Systematic Review and Meta-Analysis. J Am Soc Nephrol 2021:ASN. [PMID: 33941607 DOI: 10.1681/ASN.2020101440] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Coimbra S, Rocha S, Nascimento H, Valente MJ, Catarino C, Rocha-Pereira P, Sameiro-Faria M, Oliveira JG, Madureira J, Fernandes JC, Miranda V, Belo L, Bronze-da-Rocha E, Santos-Silva A. Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis. Clin Kidney J 2021;14:1371-8. [PMID: 33959266 DOI: 10.1093/ckj/sfaa115] [Reference Citation Analysis]